MPS 7

What is MPS 7?

Mucopolysaccharidosis type 7 (MPS 7) is an inherited metabolic disorder. Like other types of MPS disease, MPS 7 is caused by an enzyme deficiency in the processing of glycosaminoglycans (GAGs). In MPS 7, patients lack the enzyme, beta-glucuronidase, which is required for the degradation of the GAGs dermatan sulfate (DS), heparan sulfate (HS), and chondroitin 6 sulfate (CS). 

MPS 7 is also called Sly Syndrome, as it was first described by Dr. William Sly in 1973. It is an extremely rare form of MPS.

Patients with MPS 7 may experience joint stiffness, short stature, an enlarged spleen and liver and heart / lung complications. MPS 7 also causes a characteristic facial appearance and can lead to a progressive skeletal dysplasia. Hearing loss, cataracts and clouding of the corneas are also symptoms of patients with MPS 7. In more severe cases, there may be developmental delay. The severe form of MPS 7 can uniquely present at birth with hydrops fetalis (severe generalized edema). This is a very severe neonatal condition in which the child retains an enormous amount of fluid throughout the body. More than half of infants with hydrops fetalis do not survive beyond early infancy. Some adults with MPS 7 can have a less severe physical or skeletal disease.

Treatments

 

Patient Support

International MPS Network

Country organizations include:

Australia
Austria
Belgium
Brazil
Canada
France
Germany
Hong Kong
Hungary
Ireland
Italy
Netherlands
New Zealand
Poland
Spain
Switzerland
Taiwan
Turkey
UK
US National MPS Society

If you are a member of an MPS patient organization and would like to be listed here, please contact us.

Current Activities

Name

Address

Contact